The Latin America Neurovascular Catheters market size is expected to reach US$ 367.8 million by 2033 from US$ 191.9 million in 2024. The market is estimated to record a CAGR of 7.5% from 2025 to 2033.
Countries across the region invest in healthcare infrastructure, clinician training, and advanced interventional technologies to manage stroke and other neurovascular conditions. Brazil stands out as the largest market due to its large population, developed healthcare infrastructure, and increasing procedural volume for catheter‑based treatments such as mechanical thrombectomy and aneurysm embolization. Mexico and Argentina show promising growth supported by rising healthcare expenditure, expanded access to diagnostic imaging, and targeted public health efforts to improve stroke care pathways.
Stroke remains a leading cause of death and long‑term disability in Latin America, with ischemic strokes constituting the majority of cases. This prevalence has driven higher adoption of catheter‑based mechanical thrombectomy procedures in tertiary hospitals, elevating demand for thrombectomy, microcatheter, and embolization catheter systems. Embolization catheters accounted for a significant share of the market, reflecting the increasing prevalence of aneurysms and arteriovenous malformations that require minimally invasive endovascular treatment.
Healthcare modernization initiatives in urban centers have led hospitals to upgrade their interventional suites with biplane imaging systems and hybrid angiography labs, reinforcing demand for advanced catheters. Coated catheters are gaining traction for infection control, and multi‑lumen catheters are used in critical care settings to support simultaneous therapeutic delivery. Across Latin America, hospitals and clinics dominate end user adoption due to their procedural volumes and reimbursement structures. Collaborations between global device manufacturers and local distributors, along with clinician training programs and procedural support, are helping expand catheter availability and clinical confidence. Rising disease burden, infrastructure investment, and technology adoption underpin Latin America’s market trajectory through 2033.

Key segments that contributed to the derivation of the Latin America Neurovascular Catheters market analysis are product, coating type, lumen, and end user.
Stroke remains one of the leading causes of death and long‑term disability across Latin America, and ischemic strokes — which account for most cases — rely on catheter‑based mechanical thrombectomy as a standard of care. Neurovascular catheters are essential in these procedures, enabling interventional neurologists and radiologists to navigate tortuous intracranial vessels, engage and retrieve clots, and restore blood flow rapidly, improving functional outcomes and reducing neurological damage.
Cerebral aneurysms and other vascular malformations are being detected more frequently due to broader access to CT angiography and MRI in major hospitals in Brazil, Mexico, and Argentina. This access has increased procedural volumes for endovascular aneurysm treatment, including coil embolization and flow diversion techniques that depend on microcatheters and specialized embolization catheters for precise device delivery. The adoption of these advanced therapies is fostered by improvements in healthcare infrastructure, including hybrid angiography labs and dedicated stroke units in urban tertiary centers. Public health campaigns are improving awareness about stroke prevention and early intervention, while rising investments in healthcare — both public and private — are expanding access to neuro interventional procedures. These factors are driving sustained demand for neurovascular catheters across Latin America, as clinicians adopt minimally invasive therapies to address the increasing cerebrovascular disease burden.
As the demand for advanced neuro interventional procedures such as mechanical thrombectomy and aneurysm embolization is rising, hospitals and clinical centers are partnering with global device makers to gain access to catheter technologies, procedural training, and clinical support. These collaborations help bridge the gap between advanced product availability and clinical adoption, particularly in markets where in‑hospital procedural experience and specialized training have historically lagged compared to developed regions. MedTech companies benefit from direct engagement with clinical stakeholders in Latin American centers, gaining insights into regional anatomical, procedural, and logistical considerations that influence catheter design and performance. Through co‑development agreements, long‑term supply contracts, and educational programs featuring simulation‑based training, manufacturers can tailor product portfolios to better meet local clinical needs while accelerating adoption. Hospitals and clinicians gain early access to next‑generation catheter systems, structured training pathways, and post‑market support that enhances procedural proficiency and patient outcomes.
Clinical research collaborations between industry and academic hospitals allow Latin American centers to contribute real‑world data to global evidence bases that support regulatory approvals, guideline updates, and reimbursement decisions. Hospitals involved in such studies become reference centers, fostering wider regional acceptance of neurovascular catheter systems and elevating procedural volumes. Commercially, strategic engagements with leading hospital networks, stroke center alliances, and healthcare payors provide MedTech firms with stable procurement channels and broader market penetration. In emerging markets such as Argentina and Colombia, where infrastructure and training variance is significant, partnerships help overcome barriers to adoption by improving clinician confidence and post‑sale support. As healthcare systems continue shifting toward minimally invasive, value‑based care models, strategic collaborations between MedTech companies and hospitals will be instrumental in expanding access to neurovascular catheter technologies and sustaining market growth.
The Latin America neurovascular catheters market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report further examines subsegments categorized within product, coating type, lumen, and end user, offering insights into their contribution to overall market performance.
By product, the thrombectomy catheter subsegment dominated the market in 2024, driven by the widespread adoption of mechanical thrombectomy for ischemic stroke.
Per coating type, the coated catheters subsegment dominated the market in 2024, driven by infection prevention priorities.
Based on lumen, the multi-lumen subsegment dominated the market in 2024, driven by the preference for versatile therapy delivery.
By end user, the hospitals and clinics subsegment dominated the market in 2024, driven by robust hospital procedural capacity and infrastructure.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 191.9 Million |
| Market Size by 2033 | US$ 367.8 Million |
| CAGR (2025 - 2033) | 7.5% |
| Historical Data | 2022-2023 |
| Forecast period | 2025-2033 |
| Segments Covered | By Product
|
| Regions and Countries Covered | Latin America
|
| Market leaders and key company profiles |
|
The "Latin America Neurovascular Catheters Market Size and Forecast (2025-2033)" report provides a detailed analysis of the market covering below areas:
The geographical scope of the Latin America Neurovascular Catheters market report is divided into: Mexico, Brazil, Argentina, Peru, Chile, and Colombia. Brazil held the largest share in 2024.
The Latin America neurovascular catheters market exhibits diverse dynamics across regional countries, shaped by healthcare investment, access to advanced procedures, and disease prevalence. Brazil is the largest market, driven by its large population, growing stroke burden, and expanding hospital infrastructure with dedicated neuro interventional suites and hybrid angiography labs. Cities such as São Paulo and Rio de Janeiro are focal points for catheter‑based stroke and aneurysm interventions, contributing a substantial share of regional procedural volumes.
Mexico follows closely as a high‑potential market, with increasing public and private sector investments in healthcare and clinical capabilities. Expansion of stroke centers and specialized neurology units in urban hospitals is enhancing access to mechanical thrombectomy, embolization, and related catheter‑based treatments. Argentina shows promising growth as tertiary care hospitals in Buenos Aires and other metropolitan areas scale neuro interventional services and partnerships with global device makers improve catheter availability. Countries such as Chile, Colombia, and Peru are adopting advanced procedures as healthcare infrastructure develops and awareness of stroke management grows. Across Latin America, hospitals and clinics dominate end user adoption due to procedural throughput and reimbursement structures, although diagnostic imaging centers are integrating interventional capabilities to support catheter‑based workflows. Regional differences in infrastructure and healthcare funding remain, but shared trends — such as rising neurological disease incidence and investment in catheter‑based care — provide a broad foundation for market growth.

The Latin America Neurovascular Catheters market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Latin America neurovascular catheters market are:
The Latin America Neurovascular Catheters Market is valued at US$ 191.9 Million in 2024, it is projected to reach US$ 367.8 Million by 2033.
As per our report Latin America Neurovascular Catheters Market, the market size is valued at US$ 191.9 Million in 2024, projecting it to reach US$ 367.8 Million by 2033. This translates to a CAGR of approximately 7.5% during the forecast period.
The Latin America Neurovascular Catheters Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Latin America Neurovascular Catheters Market report:
The Latin America Neurovascular Catheters Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Latin America Neurovascular Catheters Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Latin America Neurovascular Catheters Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)